Delivery Order SPE2DB22D1106-SPE2DB25FEYJ6
Award Date 7/17/25
Potential Completion Date 7/18/25
Potential Value $17K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Pulmozyme 1 mg/ml ampuls (2.5 ml). The contract has a ceiling value of $4,604.30 and a period of performance through November 28, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and DLA Troop Support Medical, which serves as a primary vehicle...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Pulmozyme 1 mg/ml ampul 2.5 ml, a pharmaceutical product. The contract has a firm fixed price, a ceiling value of $7,300.97, and a period of performance through June 24, 2025. This award is not designated as a set-aside contract. AmerisourceBergen Drug Corp is the prime...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Pulmozyme 1 mg/ml ampul 2.5 ml, a medication used to treat respiratory conditions. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $3,543.92 and a period of performance ending on June 24, 2025. It is not designated as a set-aside contract. Amerisourcebergen Drug...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Pulmozyme 1 mg/ml ampul 2.5 ml. The firm-fixed-price contract has a ceiling value of $2,583.60 and a period of performance through April 28, 2025. The contract is not set aside for any specific business type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $95,689.45 fixed-price delivery order is for the supply of Pulmozyme 1 mg/mL ampules, a respiratory medication. The contract has an ultimate completion date of January 24, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,295,500 units of PULMOZYME 1 MG/ML AMPUL 2.5ML, a pharmaceutical product. The contract has a ceiling value of $11,195.24 and is structured as a Firm Fixed Price Delivery Order. It does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The $6,130.24 order is for the delivery of PULMOZYME 1 MG/ML AMPUL 2.5ML, a pharmaceutical product, to support military treatment programs and facilities. The order does not have a set-aside designation and is being provided under an indefinite...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $15,209.25, is for the delivery of PULMOZYME 1 MG/ML AMPUL 2.5ML, a medical product. The contract is a Firm Fixed Price Delivery Order with a completion date of March 12, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with...
- This is a delivery order awarded to Amerisourcebergen Drug Corporation by the Defense Logistics Agency (DLA) for the supply of Pulmozyme 1 mg/mL ampules. The contract is valued at $10,129.21 and has a firm fixed price pricing type. The place of performance is Conshohocken, Pennsylvania, and the ultimate completion date is September 25, 2024. This contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The contract provides for the delivery of PULMOZYME 1 MG/ML AMPUL 2.5ML, a pharmaceutical product, to support military treatment programs and facilities. The award has a ceiling value of $2,666.24 and a performance period through April 2, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which...